181 related articles for article (PubMed ID: 17708747)
1. New properties of inclusion bodies with implications for biotechnology.
Peternel S; Jevsevar S; Bele M; Gaberc-Porekar V; Menart V
Biotechnol Appl Biochem; 2008 Apr; 49(Pt 4):239-46. PubMed ID: 17708747
[TBL] [Abstract][Full Text] [Related]
2. Production of recombinant human G-CSF from non-classical inclusion bodies in Escherichia coli.
Trinh NTM; Thuoc TL; Thao DTP
Braz J Microbiol; 2021 Jun; 52(2):541-546. PubMed ID: 33483893
[TBL] [Abstract][Full Text] [Related]
3. The pre-induction temperature affects recombinant HuGM-CSF aggregation in thermoinducible Escherichia coli.
Restrepo-Pineda S; Sánchez-Puig N; Pérez NO; García-Hernández E; Valdez-Cruz NA; Trujillo-Roldán MA
Appl Microbiol Biotechnol; 2022 Apr; 106(8):2883-2902. PubMed ID: 35412129
[TBL] [Abstract][Full Text] [Related]
4. Expression of membrane beta-barrel protein in E. coli at low temperatures: Structure of Yersinia pseudotuberculosis OmpF porin inclusion bodies.
Solov'eva TF; Bakholdina SI; Khomenko VA; Sidorin EV; Kim NY; Novikova OD; Shnyrov VL; Stenkova AM; Eremeev VI; Bystritskaya EP; Isaeva MP
Biochim Biophys Acta Biomembr; 2022 Sep; 1864(9):183971. PubMed ID: 35643329
[TBL] [Abstract][Full Text] [Related]
5. One-step heating strategy for efficient solubilization of recombinant spider silk protein from inclusion bodies.
Cai H; Chen G; Yu H; Tang Y; Xiong S; Qi X
BMC Biotechnol; 2020 Jul; 20(1):37. PubMed ID: 32650749
[TBL] [Abstract][Full Text] [Related]
6. Influence of pH control in the formation of inclusion bodies during production of recombinant sphingomyelinase-D in Escherichia coli.
Castellanos-Mendoza A; Castro-Acosta RM; Olvera A; Zavala G; Mendoza-Vera M; García-Hernández E; Alagón A; Trujillo-Roldán MA; Valdez-Cruz NA
Microb Cell Fact; 2014 Sep; 13():137. PubMed ID: 25213001
[TBL] [Abstract][Full Text] [Related]
7. Refolding of Proteins Expressed as Inclusion Bodies in E. coli.
Sharma R; Anupa A; Rathore AS
Methods Mol Biol; 2023; 2617():201-208. PubMed ID: 36656526
[TBL] [Abstract][Full Text] [Related]
8. Expression and purification of recombinant human granulocyte colony-stimulating factor in fed-batch culture of Escherichia coli.
Kim CK; Choi JH; Lee SB; Lee SM; Oh JW
Appl Biochem Biotechnol; 2014 Mar; 172(5):2425-35. PubMed ID: 24390866
[TBL] [Abstract][Full Text] [Related]
9. Influence of production process design on inclusion bodies protein: the case of an Antarctic flavohemoglobin.
Parrilli E; Giuliani M; Marino G; Tutino ML
Microb Cell Fact; 2010 Mar; 9():19. PubMed ID: 20334669
[TBL] [Abstract][Full Text] [Related]
10. Active protein aggregates produced in Escherichia coli.
Peternel S; Komel R
Int J Mol Sci; 2011; 12(11):8275-87. PubMed ID: 22174663
[TBL] [Abstract][Full Text] [Related]
11. Refolding and structural characteristic of TRAIL/Apo2L inclusion bodies from different specific growth rates of recombinant Escherichia coli.
Kang H; Sun AY; Shen YL; Wei DZ
Biotechnol Prog; 2007; 23(1):286-92. PubMed ID: 17269700
[TBL] [Abstract][Full Text] [Related]
12. Recombinant production of ESAT-6 antigen in thermoinducible Escherichia coli: the role of culture scale and temperature on metabolic response, expression of chaperones, and architecture of inclusion bodies.
Restrepo-Pineda S; Bando-Campos CG; Valdez-Cruz NA; Trujillo-Roldán MA
Cell Stress Chaperones; 2019 Jul; 24(4):777-792. PubMed ID: 31165436
[TBL] [Abstract][Full Text] [Related]
13. Exploring the use of leucine zippers for the generation of a new class of inclusion bodies for pharma and biotechnological applications.
Roca-Pinilla R; Fortuna S; Natalello A; Sánchez-Chardi A; Ami D; Arís A; Garcia-Fruitós E
Microb Cell Fact; 2020 Sep; 19(1):175. PubMed ID: 32887587
[TBL] [Abstract][Full Text] [Related]
14. Teaching an old pET new tricks: tuning of inclusion body formation and properties by a mixed feed system in E. coli.
Wurm DJ; Quehenberger J; Mildner J; Eggenreich B; Slouka C; Schwaighofer A; Wieland K; Lendl B; Rajamanickam V; Herwig C; Spadiut O
Appl Microbiol Biotechnol; 2018 Jan; 102(2):667-676. PubMed ID: 29159587
[TBL] [Abstract][Full Text] [Related]
15. Production of nonclassical inclusion bodies from which correctly folded protein can be extracted.
Jevsevar S; Gaberc-Porekar V; Fonda I; Podobnik B; Grdadolnik J; Menart V
Biotechnol Prog; 2005; 21(2):632-9. PubMed ID: 15801811
[TBL] [Abstract][Full Text] [Related]
16. Recombinant-phospholipase A2 production and architecture of inclusion bodies are affected by pH in Escherichia coli.
Calcines-Cruz C; Olvera A; Castro-Acosta RM; Zavala G; Alagón A; Trujillo-Roldán MA; Valdez-Cruz NA
Int J Biol Macromol; 2018 Mar; 108():826-836. PubMed ID: 29101045
[TBL] [Abstract][Full Text] [Related]
17. Method for Inclusion Bodies Production via E. coli Host System: rGCSF as Model Biotherapeutic Protein.
Rani AK; Naira VR; Rathore AS
Methods Mol Biol; 2023; 2617():249-256. PubMed ID: 36656530
[TBL] [Abstract][Full Text] [Related]
18. Production of Active Recombinant Hyaluronidase Inclusion Bodies from
Schwaighofer A; Ablasser S; Lux L; Kopp J; Herwig C; Spadiut O; Lendl B; Slouka C
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485932
[TBL] [Abstract][Full Text] [Related]
19. Production of functional inclusion bodies in endotoxin-free Escherichia coli.
Rueda F; Cano-Garrido O; Mamat U; Wilke K; Seras-Franzoso J; García-Fruitós E; Villaverde A
Appl Microbiol Biotechnol; 2014 Nov; 98(22):9229-38. PubMed ID: 25129611
[TBL] [Abstract][Full Text] [Related]
20. Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma.
Krachmarova E; Ivanov I; Nacheva G
Microb Cell Fact; 2020 Jul; 19(1):139. PubMed ID: 32652996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
